Global, Open RFID Standards Provide Interoperability to Meet the Demands of Critical Medication Needed During the Covid-19 Pandemic
IntelliGuard, the global leader in radio-frequency identification (RFID) medication management technology, announced today the release of its GS1 readability capabilities, which adhere to a global RFID standard. An industry first in medication automation, IntelliGuard’s distinct ability to read GS1 labels means that any medication with a compliant RFID smart label is now compatible with the company’s medication management technology, providing real-time inventory management, product location and identification.
To read more, follow the link below to the source.
Source: prnewswire.com